Table I.

Effects of curcumin on cardiac function and morphology.

Group	Time	LVEF (%)	LVFS (%)	AO (mm)	LVPW (mm)	IVS (mm)
Con	Pre	74.2±3.8	39.9±3.3	7.1±0.2	2.1±0.2	2.1±0.1
	Post	74.0±3.4b	39.8±2.9b	7.1±0.3b	2.2±0.1b	2.2±0.2b
Con-cur	Pre	71.4±8.9	38.0±7.4	7.1±0.6	2.2±0.4	2.1±0.3
	Post	70.6±7.2	37.2±5.6	7.2±0.5	2.2±0.5	2.2±0.3
CHF	Pre	72.1±6.0	38.2±5.0	7.2±0.40	2.2±0.3	2.1±0.4
	Post	32.1±8.8a,c	14.1±4.5a,c	10.3±1.5a,c	3.1±0.4a,c	4.1±0.8a,c
CHF-cur	Pre	70.2±5.3	36.7±4.1	7.2±0.4	2.0±0.2	2.1±0.2
	Post	48.3±12.9a,d	23.0±7.2a,d	8.7±0.5a,d	2.6±0.3a,d	3.1±0.3a,d

Data are expressed as the mean ± standard deviation (n=10). All data are expressed as the mean ± standard deviation (n=10).

^aP<0.05 postoperative parameters vs. preoperative ones

^bP <0.05 vs. postoperative parameters of CHF group

^cP<0.05 vs. postoperative parameters of CHF-cur group

^dP<0.05 vs. postoperative parameters of Con group. AO, aortic diameter; IVS, interventricular septum thickness; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; LVPW, left ventricular posterior wall thickness; Post, postoperative; Pre, preoperative.